Filing Details

Accession Number:
0001104659-15-024705
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-31 17:57:24
Reporting Period:
2015-03-30
Filing Date:
2015-03-31
Accepted Time:
2015-03-31 16:57:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356576 Supernus Pharmaceuticals Inc SUPN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1540660 W. Jones Bryan C/O Supernus Pharmaceuticals, Inc.
1550 East Gude Drive
Rockville MD 20850
Vp Of Business Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-30 6,712 $2.56 74,692 No 4 M Direct
Common Stock Disposition 2015-03-30 6,712 $12.02 67,980 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-03-30 6,712 $0.00 6,712 $2.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,763 2020-11-02 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a Rule 10b5-1 trading plan adopted on April 21, 2014.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.0000 to $12.1000, inclusive. The reporting person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
  3. The option vested in four equal annual installments beginning on November 2, 2011.